Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Dow Inc. DOW

Basic Materials — Chemicals
S&P 500 Member
Indexes indicate stock being part of an index

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership
0.42%

Capital & Financial Ratios

Market Cap
21,280.00
Revenue
41,319.00
Net Income
(996.00)
Free Cash Flow
1,676.00
Net Debt
13,936.00
Current Ratio
1.75
Debt/Equity
1.03
P/E ratio
0.00
P/S ratio
0.52
P/B ratio
1.23
Past 5Y EPS Growth
(33.38%)
This Y EPS Growth
352.56%
Next Y EPS Growth
(30.39%)
Next 5Y EPS Growth
(26.34%)
in millions of $

Dividends

Payout Ratio
1.52
Annual Dividend Rate
2.80
Annual Dividend Yield
5.37%
total individual payouts
2028 ‡‡‡‡
2027 ‡‡‡‡‡
2026 1.39
—
—
—
2025 2.10
—
—
—
—
2024 2.80
—
—
—
—
2023 2.80
—
—
—
—
2022 2.80
—
—
—
—
2021 2.80
—
—
—
—
2020 2.80
—
—
—
—
2019 2.10
—
—
—
2017 1.38
—
—
—
2016 1.84
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 2,987.00 2,189.00 3,816.00 3,973.00
Receivables 6,614.00 6,864.00 6,638.00 8,479.00
Inventory 6,076.00 6,544.00 6,595.00 7,233.00
Other 1,937.00 993.00 1,013.00 1,186.00
17,614.00 16,590.00 18,062.00 20,871.00
2023 2024 2025 Q'26
Payables 6,326.00 6,541.00 5,545.00 7,007.00
ST’ Debt 117.00 497.00 222.00 758.00
Other — — — —
9,957.00 10,288.00 9,183.00 11,931.00
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow — ‡‡‡‡‡ ‡‡‡‡‡
Earnings — ‡‡‡ ‡‡‡
Book Value — ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 9,794.00 12,092.00 — —
—
’25 10,431.00 10,104.00 9,973.00 9,460.00
39,968.00
’24 10,765.00 10,915.00 10,879.00 10,405.00
42,964.00
’23 11,851.00 11,420.00 10,730.00 10,621.00
44,622.00
’22 15,264.00 15,664.00 14,115.00 11,859.00
56,902.00
’21 11,882.00 13,885.00 14,837.00 14,364.00
54,968.00
’20 9,770.00 8,354.00 9,712.00 10,706.00
38,542.00
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 1,124.00 1,331.00 — —
—
’25 91.00 (470.00) 1,127.00 284.00
1,032.00
’24 464.00 836.00 800.00 814.00
2,914.00
’23 535.00 1,361.00 1,644.00 1,656.00
5,196.00
’22 1,603.00 1,890.00 1,904.00 2,078.00
7,475.00
’21 (291.00) 2,004.00 2,721.00 2,575.00
7,009.00
’20 1,239.00 1,590.00 1,767.00 1,630.00
6,226.00
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 647.00 726.00 — —
—
’25 (621.00) (1,042.00) 657.00 (354.00)
(1,360.00)
’24 (300.00) 75.00 31.00 199.00
5.00
’23 95.00 732.00 1,001.00 885.00
2,713.00
’22 1,253.00 1,390.00 1,407.00 1,437.00
5,487.00
’21 (582.00) 1,656.00 2,291.00 1,425.00
4,790.00
’20 850.00 1,318.00 1,759.00 1,966.00
5,893.00
in millions of $

EPS

Mar Jun Sep Dec Year
’26 (0.74) 0.99 — —
—
’25 (0.44) (1.18) 0.08 (2.15)
(3.70)
’24 0.73 0.62 0.30 (0.08)
1.57
’23 (0.13) 0.68 0.42 (0.15)
0.82
’22 2.11 2.26 1.02 0.85
6.28
’21 1.32 2.51 2.23 2.32
8.38
’20 0.32 (0.31) (0.04) 1.65
1.64

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

2.4
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 42.91 47.26 38.85 20.40 — — —
Low Price
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 71.86 60.88 60.69 42.17 — — —
High Price
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 37,800 35,900 36,000 34,600 — — —
Employees
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.51 1.24 1.19 1.16 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 56,902.00 44,622.00 42,964.00 39,968.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 15.05% 10.94% 10.72% 6.34% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 6,090.00 656.00 1,600.00 (2,511.00) — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.70% 1.47% 3.72% (6.28%) ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4,640.00 660.00 1,201.00 (2,444.00) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,758.00 2,611.00 2,894.00 2,834.00 — — —
Depreciation
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 78.92 63.23 61.05 56.17 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
— — ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 6.36 0.82 1.57 (3.70) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡
Earnings/Sh
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.37 7.36 4.14 1.45 — — —
Cash Flow/Sh
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (2.76) (3.52) (4.13) (3.36) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7.61 3.84 0.01 (1.91) — — —
Free CF/Sh
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 29.47 27.08 25.36 24.62 — — —
Book Value/Sh
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 721.00 705.70 703.80 711.60 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.11 66.66 25.56 0.00 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.65 0.88 0.66 0.42 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.73 2.04 1.58 0.95 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.84 1.14 0.98 0.77 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.74 18.83 8,452.50 (22.71) — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7,475.00 5,196.00 2,914.00 1,032.00 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1,988.00) (2,483.00) (2,909.00) (2,392.00) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5,487.00 2,713.00 5.00 (1,360.00) — — —
FCF
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9,146.00 7,657.00 6,302.00 8,879.00 — — —
Working Cap'
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 15,060.00 15,024.00 16,208.00 18,071.00 — — —
Total Debt
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11,174.00 12,037.00 14,019.00 14,255.00 — — —
Net Debt
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 21,247.00 19,108.00 17,851.00 17,522.00 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7.38% 0.99% 1.94% (4.53%) — — —
ROA
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.76% 3.15% 3.53% (3.34%) — — —
ROIC
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 22.80% 2.92% 6.04% (14.83%) — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Dow Inc. (DOW), the materials science powerhouse spun off from DowDuPont in 2019, is navigating the brutal cycles of the chemicals sector after a post-COVID revenue peak of $56.9 billion in 2022 gave way to a sharp 2024 drop to $43 billion. Margin compression from soaring energy costs—exacerbated by the Ukraine war and volatile feedstocks—has crushed profitability, with gross margins slumping to a projected 6.3% in 2025, EBT turning negative at -$2.5 billion, and EPS diving to -$3.70. Free cash flow per share has evaporated from $7.61 peaks to near-zero, while debt climbs and ROIC goes red, mirroring stock lows around $39 amid softer demand from China, Europe, and U.S. housing.

Yet amid the gloom, analyst forecasts sketch a gritty rebound: revenue stabilizing around $40 billion in 2025-26 before climbing 3-4% annually through 2028, with EPS tripling to $1.80 by then on potential U.S. reshoring tailwinds, Gulf Coast LNG advantages, and Fed rate cuts boosting autos and construction. Valuation looks dirt-cheap—PS at 0.42x, PB at 0.96x—versus peers, though price targets imply 14% downside on near-term weakness, with neutral insiders offering no vote of confidence.

DOW’s story is classic cyclical resilience laced with macro wildcards: OPEC+ oil discipline and PMI recovery could spark a 2026-28 inflection, lifting margins 300-500bps and turning this beaten-down value play into a high-conviction hold for patient investors. Watch Q1 2026 earnings for the pivot—downside risks loom if recession hits, but at these levels, the setup screams opportunity.

Read full commentary →

Dow Inc. (DOW) Latest News

News by impact score

Fine-tune

19 Sep

4 , 12:11 PM
Dow Inc. advances AI-driven efficiency measures and expands SupraCare operations, altering its investment narrative. AI efficiency push combined with SupraCare growth represents major strategic moves likely to shift company trajectory and investor views.

14 Sep

4 , 10:39 AM
Dow rethinks its planned $20 billion chemicals investment in Saudi Arabia. Reconsidering a $20 billion Saudi project represents a major strategic shift with direct effects on Dow's capital plans and growth outlook.

9 Sep

4 investorshub.advfn.com, 8:59 AM
Dow Inc. explores potential exit from its $20 billion chemicals venture with Saudi Aramco. Exit from major venture represents strategic shift likely to affect Dow's operations and finances substantially.

4 Sep

3 , 8:19 AM
Dow Inc. shares rally 30% year to date on positive momentum drivers. YTD rally signals company-specific developments with moderate ongoing effects on performance and sentiment.

1 Sep

3 , 4:12 AM
Dow Inc. introduces a new dividend, prompting assessment of whether the stock remains undervalued or if market gains are already priced in. New dividend affects Dow valuation and investor sentiment with limited fundamental shifts to operations or trajectory.

23 Aug

3 www.thestreet.com, 6:33 PM
Dow Inc. is positioned as central to the next major oil trade, independent of traditional oil stocks. Oil trade positioning for Dow Inc. may moderately shift market sentiment and performance.

21 Aug

3 , 7:27 AM
Dow Inc. stock is recommended for retention in portfolios due to favorable fundamentals and outlook supporting continued holding. Retention advice signals moderate influence on sentiment and positioning without major strategic or transformative shifts.

30 Jul

4 , 3:09 AM
Dow Inc. installs new CEO to lead transformation restoring profitability amid oil market upheaval. New CEO transformation targets profitability restoration in volatile oil markets, indicating major strategic shift with significant future impact.

24 Jul

4 , 5:11 PM
Dow Inc. reports strong Q2 results driven by pricing strategies and cost actions. Strong Q2 results from pricing and cost actions boost Dow's financial outlook and market performance.

4 , 10:00 AM
Dow Inc. emphasized cost reduction measures and portfolio adjustments in its Q2 earnings call. Cost actions and portfolio shifts represent major strategic moves likely to alter Dow's operational trajectory and investor outlook.

3 transcript app.moby.co, 8:30 AM
Dow Inc. presented Q2 2026 financial results and outlook during its earnings call. Quarterly earnings data typically influence near-term investor sentiment and stock movement.

23 Jul

3 , 3:01 PM
Dow Inc reported strong Q2 2026 sales growth despite market challenges. Q2 sales growth amid challenges points to moderate effects on Dow Inc performance and sentiment.

3 , 10:45 AM
Dow Inc. Q2 earnings beat estimates due to higher pricing and self-help actions. Q2 earnings beat from pricing gains and self-help actions signals moderate positive effects on financials and sentiment.

3 investorshub.advfn.com, 8:38 AM
Dow Inc. surpassed second-quarter earnings expectations, with pricing strength driving the earnings lift. Earnings beat from pricing gains points to near-term profitability gains but lacks signals of major strategic shifts.

3 , 6:00 AM
Dow Inc. reported its second quarter 2026 results. Quarterly earnings results typically deliver financial metrics that moderately influence near-term stock performance.

21 Jul

3 , 7:00 AM
Dow Inc. (DOW) approaches Q2 earnings as analysts assess whether the stock warrants a buy, sell, or hold rating. Earnings preview with buy/sell/hold opinion can moderately sway short-term investor sentiment toward DOW.

2 Jul

3 www.barchart.com, 8:43 AM
Dow Inc. prepares to release earnings with investors advised on key expectations, financial metrics, and market context ahead of the report. Preview of Dow Inc. earnings may moderately sway short-term stock sentiment without altering long-term fundamentals.

1 Jul

3 , 10:41 AM
RBC downgrades Dow Inc. citing falling polyethylene prices and rising Alberta Cracker project spend. Downgrade flags profitability pressure from price weakness and higher costs that may affect near-term stock sentiment.

3 , 8:35 AM
RBC cuts Dow Inc. price target by 45% and warns recent rally may not last. Sharp analyst price target reduction signals potential valuation concerns and may pressure near-term stock sentiment.

3 , 6:23 AM
Dow Inc. partners with Univar Solutions to distribute its Decarbia low-carbon portfolio. Distribution partnership expands reach for Dow low-carbon products with moderate sales and positioning upside.

30 Jun

4 , 4:20 PM
Dow Inc. endures prolonged stock declines amid weak chemical demand, operational challenges and strategic setbacks that have eroded investor confidence and market position. Dow's extended losing streak reflects core operational weaknesses likely to pressure future earnings and stock trajectory.

3 , 11:24 AM
Dow Inc. stock faces an extended losing streak driven by sustained market pressures and operational challenges. Prolonged share-price declines signal ongoing negative momentum likely to affect near-term investor sentiment.

25 Jun

4 Zacks, 9:12 AM
Dow Inc. announces $100 million investment to expand silicone capabilities. $100 million investment marks major strategic move to expand silicone capabilities and strengthen Dow's positioning.

23 Jun

3 Insider Monkey, 9:37 AM
Dow Inc. (DOW) gains from tightened global polyethylene markets. Tightened polyethylene markets support higher margins in Dow's core chemicals operations.

3 Simply Wall St., 6:14 AM
Dow Inc. faces a lawsuit alleging links between its chlorpyrifos pesticide and Parkinson's disease, challenging prior safety claims. Lawsuit over chlorpyrifos safety introduces legal costs, regulatory risk and potential business restrictions for Dow's pesticide segment.

12 Jun

3 , 9:10 PM
Dow Inc. implements layoffs and completes a Xylem deal, adjusting cost structures, valuation metrics, and long-term return expectations. Layoffs cut costs and Xylem deal shifts valuation yet effects remain moderate on overall trajectory.

10 Jun

3 Zacks, 10:31 AM
Dow Inc. partners with Xylem to advance its Path2Zero project. Partnership supports sustainability initiative with moderate operational relevance.

2 Jun

3 Zacks, 11:37 AM
Dow Inc. partners with Univar to expand accessibility of low-carbon products. Partnership broadens low-carbon product distribution and may moderately strengthen market positioning in sustainability.

1 Jun

3 Zacks, 8:11 AM
Dow Inc. launches DOWSIL TC-3120 Thermal Gel for advanced electronics applications. New thermal gel supports product innovation in electronics with limited overall company impact.

31 May

3 Insider Monkey, 10:21 AM
Citi revises Dow Inc. outlook lower amid emerging demand destruction concerns. Citi outlook revision signals demand risks that may moderately affect Dow performance and sentiment.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us